FDA Inspection
Taejoon Pharmaceutical Co., Ltd.Taejoon Pharmaceutical Co., Ltd. – FDA Inspection, Oct 18, 2022
Record Details
This FDA Inspection record concerns Taejoon Pharmaceutical Co., Ltd., with an inspection on October 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 18, 2022
- Product Type
- Drugs
View Company Profile
ID · 0a99edfc-34a3-45ad-affd-9bd3e671a129
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1182340
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Taejoon Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 15, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2018 | Not classified | Office of Inspections and Investigations | |
| November 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taejoon Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.